促进更好的临床试验和药物信息作为意大利 COVID-19 紧急情况的公共卫生干预措施。
Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy.
机构信息
Regional Health Service, Regione Lazio, Rome, Italy (A.A.).
Università Del Piemonte Orientale, Novara, Italy (A.G.).
出版信息
Ann Intern Med. 2020 Oct 20;173(8):654-655. doi: 10.7326/M20-3775. Epub 2020 Jun 16.
Abstract
According to these authors from the Italian Medicines Agency, “evidence-informed prescribing and clinical trials were beaten off the mark by social media, rumors, and panic in the early phase of the COVID-19 pandemic.” In this article, they describe lessons learned to counteract misleading information and nudge the research community to do high-quality, informative multigroup trials.
摘要
据意大利药品管理局的这些作者称，“在 COVID-19 大流行的早期阶段，基于证据的处方和临床试验被社交媒体、谣言和恐慌所击败。” 在本文中，他们描述了吸取的教训，以对抗误导性信息，并促使研究界开展高质量、信息丰富的多组试验。
相似文献
1
Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy.促进更好的临床试验和药物信息作为意大利 COVID-19 紧急情况的公共卫生干预措施。
Ann Intern Med. 2020 Oct 20;173(8):654-655. doi: 10.7326/M20-3775. Epub 2020 Jun 16.
2
Timely adaptation of a Pediatric Unit to COVID-19 emergency in Northern Italy: the experience of Fondazione IRCCS Policlinico San Matteo in Pavia.意大利北部一家儿科病房对新冠疫情紧急情况的及时应对：帕维亚圣马泰奥综合医院基金会的经验。
Acta Biomed. 2020 Sep 15;91(11-S):e2020004. doi: 10.23750/abm.v91i11-S.10300.
3
Editorial: Clinical trial design in the era of COVID-19.社论：新冠疫情时代的临床试验设计
Clin Trials. 2020 Oct;17(5):465-466. doi: 10.1177/1740774520940230. Epub 2020 Jul 10.
4
What Other Countries Can Learn From Italy During the COVID-19 Pandemic.在新冠疫情期间其他国家能从意大利学到什么。
JAMA Intern Med. 2020 Jul 1;180(7):927-928. doi: 10.1001/jamainternmed.2020.1447.
5
Children and the Use of Emergency Departments During the COVID-19 Pandemic: Where Did the Pain End Up?新冠疫情期间儿童与急诊科的使用情况：痛苦究竟何在？
Pediatr Emerg Care. 2020 Nov;36(11):e670-e671. doi: 10.1097/PEC.0000000000002256.
6
A Cruel COVID-19 Irony.新冠疫情的残酷讽刺。
JAMA. 2020 Jul 28;324(4):345-346. doi: 10.1001/jama.2020.11882.
7
Personal reflections of an emergency general surgeon on the COVID-19 pandemic.一位普通外科急诊医生对新冠疫情的个人反思。
Eur J Trauma Emerg Surg. 2020 Jun;46(3):511-512. doi: 10.1007/s00068-020-01363-8. Epub 2020 Apr 20.
8
Novel 2019 coronavirus SARS-CoV-2 (COVID-19): an overview for emergency clinicians.新型2019冠状病毒SARS-CoV-2（新冠病毒病）：面向急诊临床医生的概述
Pediatr Emerg Med Pract. 2020 May 2;17(5):1-24. Print 2020 May.
9
Covid-19 in Italy: Lesson from the Veneto Region.意大利的新冠疫情：威尼托大区的经验教训。
Eur J Intern Med. 2020 Jul;77:161-162. doi: 10.1016/j.ejim.2020.05.039. Epub 2020 May 28.
引用本文的文献
1
Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemic.COVID-19 的药物和恢复期血浆疗法：大流行一年后对意大利干预性临床研究的调查。
Trials. 2022 Jun 22;23(1):527. doi: 10.1186/s13063-022-06474-8.
2
Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real Practice.新型冠状病毒肺炎门诊管理中的药物处方：循证建议与实际做法对比
Front Pharmacol. 2022 Mar 24;13:825479. doi: 10.3389/fphar.2022.825479. eCollection 2022.
3
The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review.新型冠状病毒肺炎药理学临床试验的医疗护理标准定义：一项系统评价
Front Pharmacol. 2021 Oct 18;12:749514. doi: 10.3389/fphar.2021.749514. eCollection 2021.
4
The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.2019年冠状病毒病对国家临床试验网络乳腺癌试验的影响
Curr Breast Cancer Rep. 2021;13(3):103-109. doi: 10.1007/s12609-021-00417-z. Epub 2021 May 12.
5
How COVID-19 has fundamentally changed clinical research in global health.新冠疫情如何从根本上改变了全球健康领域的临床研究。
Lancet Glob Health. 2021 May;9(5):e711-e720. doi: 10.1016/S2214-109X(20)30542-8.
6
Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy.意大利 COVID-19 大流行早期用于 COVID-19 治疗的药物和其他药物的需求比较。
JAMA Netw Open. 2021 Feb 1;4(2):e2037060. doi: 10.1001/jamanetworkopen.2020.37060.
7
Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis.新冠大流行期间心理健康问题的流行率：系统评价和荟萃分析。
J Affect Disord. 2021 Feb 15;281:91-98. doi: 10.1016/j.jad.2020.11.117. Epub 2020 Dec 3.
8
Rise and Fall: Hydroxychloroquine and COVID-19 Global Trends: Interest, Political Influence, and Potential Implications.兴衰：羟氯喹与新冠疫情全球趋势：关注度、政治影响及潜在影响
ACR Open Rheumatol. 2020 Dec;2(12):760-766. doi: 10.1002/acr2.11207. Epub 2020 Dec 2.
本文引用的文献
1
Against pandemic research exceptionalism.反对大流行研究例外论。
Science. 2020 May 1;368(6490):476-477. doi: 10.1126/science.abc1731. Epub 2020 Apr 23.
2
Drug Evaluation during the Covid-19 Pandemic.新冠疫情期间的药物评估
N Engl J Med. 2020 Jun 11;382(24):2282-2284. doi: 10.1056/NEJMp2009457. Epub 2020 Apr 14.
3
Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.创建疾病爆发期间进行随机临床试验的框架。
N Engl J Med. 2020 Apr 2;382(14):1366-1369. doi: 10.1056/NEJMsb1905390.
4
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.在大流行期间治疗新冠病毒病——超说明书用药、同情用药及随机临床试验
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
5
Covid-19 - Navigating the Uncharted.新冠疫情——探索未知领域。
N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28.
Zotero 插件